title: Hepatitis B vaccination in uremic patients: comparison between recombinant and plasma-derived vaccine.
abstract: The immune response to recombinant and plasma-derived vaccines was evaluated in 53 and 43 uremic patients, respectively. The total rate of seroconversion was around 80% with both vaccines, although a significantly higher response was obtained with the protocol using recombinant vaccine.
authors.affiliation: Servizio di Nefrologia e Dialisi, Ospedale degli Infermi, Biella, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Bergia
authors.forename: M
authors.initials: M
authors.lastname: Pellerey
authors.forename: I
authors.initials: I
authors.lastname: Berto
authors.forename: E
authors.initials: E
authors.lastname: Caramello
authors.forename: P
authors.initials: P
authors.lastname: Dionisio
authors.forename: M
authors.initials: M
authors.lastname: Valenti
authors.forename: C
authors.initials: C
authors.lastname: Converso
authors.forename: G
authors.initials: G
authors.lastname: Garbaccio
authors.forename: P
authors.initials: P
authors.lastname: Bajardi
mesh_terms: D000368:Aged; D005260:Female; D006510:Hepatitis B Antibodies / Q000097:blood; D017325:Hepatitis B Vaccines; D006801:Humans; D008297:Male; D008875:Middle Aged; D014511:Uremia / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000627:therapeutic use; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use*
chemical_list: D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines